Andrew Oxtoby
Director/Board Member at Damien Center
Andrew Oxtoby active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Damien Center | Director/Board Member | - | - |
Career history of Andrew Oxtoby
Former positions of Andrew Oxtoby
| Companies | Position | Start | End |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-02-14 | 2023-08-08 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2014-12-31 | 2018-12-31 |
Lilly Nederland Holding BV
 Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Corporate Officer/Principal | 2009-11-30 | 2012-03-31 |
| AIMMUNE THERAPEUTICS, INC. | Chief Executive Officer | - | - |
| Corporate Officer/Principal | 2019-01-21 | - | |
| President | - | - |
Training of Andrew Oxtoby
| Purdue University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistics
International
| United States | 7 |
| Netherlands | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Damien Center | |
Lilly Nederland Holding BV
Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Finance |
- Stock Market
- Insiders
- Andrew Oxtoby
- Experience
